Recent progress of hypoxia-modulated multifunctional nanomedicines to enhance photodynamic therapy: opportunities, challenges, and future development.
作者:
关键词
3O2, molecular oxygenAPCs, antigen-presenting cellsAQ4N, banoxantroneCaO2, calcium dioxideCancerCe6, chlorin e6CeO2, cerium oxideDC, dendritic cellsDDS, drug delivery systemDOX, doxorubicinEPR, enhanced permeability and retentionFDA, U.S. Food and Drug AdministrationH2O, waterH2O2, hydrogen peroxideHIF, hypoxia-inducible factorHIF-1α, hypoxia-inducible factor-1αHSA, human serum albuminHb, hemoglobinHypoxiaMB, methylene blueMDR1, multidrug resistance 1MDSC, myeloid derived suppressive cellsMn-CDs, magnetofluorescent manganese-carbon dotsMnO2, manganese dioxideNMR, nuclear magnetic resonanceNanomedicine delivery systemsO2.?, superoxide anionOH., hydroxyl radicalOxygenPDT, photodynamic therapyPFC, perfluorocarbonPFH, perfluoroethanePS, photosensitizersPhotodynamic therapyRBCs, red blood cellsROS, reactive oxygen speciesTAM, tumor-associated macrophagesTPZ, tirapazamine
DOI
10.1016/j.apsb.2020.01.004
PMID
32963938
发布时间
2023-11-12
- 浏览4

Acta pharmaceutica Sinica. B
2020年10卷8期
1382-1396页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文